Bayesian Capital Management, LP Lantheus Holdings, Inc. Transaction History

Bayesian Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $989,016 - $1.4 Million	16,800 New	16,800 $1.35 Million
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $743,149 - $1.04 Million	13,366 New	13,366 $828,000
Q2 2023 Aug 14, 2023	SELL	$82.41 - $99.65 $1.46 Million - $1.77 Million	-17,737 Reduced 76.45%	5,463 $458,000
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $1.11 Million - $1.92 Million	23,200 New	23,200 $1.92 Million
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $349,902 - $457,695	6,300 Added 84.0%	13,800 $911,000
Q1 2022 May 16, 2022	BUY	$24.28 - $56.64 $182,100 - $424,800	7,500 New	7,500 $415,000
Q2 2019 Aug 13, 2019	SELL	$23.33 - $28.3 $250,984 - $304,451	-10,758 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$14.93 - $25.1 $160,616 - $270,025	10,758 New	10,758 $263,000

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.